BrainStorm Cell Therapeutics Inc (BCLI)

[Spideyboy]

Along with the impending start to Phase III, which from my understanding it is meant to start in 2H/2017 but no real guidance given, which is prob closer to end Q3.

BCLI exited the first quarter of 2017 with 8.3 million cash, and with a 2 million burn per quarter. With that cash good enough to get thew to end Q2/2018.

While I would expect preparations to be ready and the City of Hope staff to be well trained up by now on NurOwn manufacturing.

So even with the IIA 2 million grant, my issue still is the funding for the Phase III of the 200 patients, (expecting at least a 10 million USD cost?) thus my expectation of dilution in the near term and holding off accumulating till I see the cash come in. Also again I'd rather they did do dilution that partner with royalties, as at the current ppr of 4.16, they would just need to issue 2.4-3 million shares to get the extra money I believe they would need. If the results are good, this will sell itself and will be all over the media, share price should fly from that.

What would be your thoughts?